Epigenomics AG Stock Deutsche Boerse AG
Stocks
ECX
DE000A11QW50
Biotechnology & Medical Research
OTC Markets Traded|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.785 EUR | -1.92% |
|
+9.51% | -4.03% |
| 04-02 | Epigenomics AG Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| 25-07-22 | Epigenomics AG Reports Earnings Results for the Half Year Ended June 30, 2025 | CI |
| Market Cap | 824K 954K 760K 711K 1.33M 90.72M 1.35M 8.97M 3.5M 44.16M 3.58M 3.51M 153M | P/E Ratio 2024 |
-0.29x | P/E Ratio 2025 | -2.51x |
|---|---|---|---|---|---|
| Enterprise Value | 11.79M 13.65M 10.87M 10.17M 19.06M 1.3B 19.36M 128M 50.02M 632M 51.24M 50.15M 2.19B | EV / Sales 2024 |
-
| EV / Sales 2025 | 490x |
| Free-Float |
70.75% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -1.92% |
| Manager | Title | Age | Since |
|---|---|---|---|
Frederic Hilke
IRC | Investor Relations Contact | - | - |
| Corporate Officer/Principal | 55 | 2024-01-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Helge Lubenow
CHM | Chairman | 58 | 2023-02-28 |
Alexander Link
BRD | Director/Board Member | 55 | 2020-05-31 |
Jochen Hummel
BRD | Director/Board Member | 56 | 2024-02-04 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.92% | +9.51% | - | - | 954K | |
| -0.19% | -2.87% | +79.01% | +75.36% | 3.78B | |
| -6.03% | +4.14% | +70.54% | +100.46% | 2.82B | |
| +4.05% | -2.03% | -31.58% | -39.75% | 1.94B | |
| +3.03% | -3.55% | +82.14% | -53.85% | 1.82B | |
| -2.92% | +3.24% | +23.56% | +174.76% | 1.19B | |
| -0.36% | -6.03% | -13.29% | +15.43% | 853M | |
| -0.72% | -22.50% | +92.46% | - | 782M | |
| -4.41% | -0.80% | +133.80% | -65.98% | 735M | |
| +0.66% | -4.95% | -28.20% | -15.87% | 540M | |
| Average | -0.88% | -1.15% | +45.38% | +23.82% | 1.61B | |
| Weighted average by Cap. | -0.80% | -0.54% | +52.41% | +40.66% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | 24K 27.79K 22.12K 20.7K 38.8K 2.64M 39.4K 261K 102K 1.29M 104K 102K 4.45M |
| Net income | -3.35M -3.88M -3.09M -2.89M -5.42M -369M -5.5M -36.47M -14.22M -180M -14.57M -14.26M -622M | -314K -364K -289K -271K -508K -34.56M -515K -3.42M -1.33M -16.82M -1.36M -1.34M -58.24M |
| Net Debt | 10.46M 12.1M 9.63M 9.02M 16.9M 1.15B 17.16M 114M 44.35M 560M 45.43M 44.46M 1.94B | 10.97M 12.7M 10.11M 9.46M 17.73M 1.21B 18M 119M 46.53M 587M 47.65M 46.64M 2.03B |
Employees
-
Annual profits - Rate of surprise
- Stock Market
- Stocks
- ECX Stock
- ECX Stock
Select your edition
All financial news and data tailored to specific country editions
